Abstract
Rat alveolar macrophages (AM) collected by bronchoalveolar lavage were incubated in the presence or absence of various icosanoïds or inhibitors of the arachidonic acid cascade with either chrysotile asbestos (50 ug/ml) to determine cell aggregation, or human red blood cells (Rh +; preincubated with anti-D globulin) to measure phagocytosis. Phorbol myristate acetate (PMA) and ionophore A23187, two agents which stimulate arachidonic acid metabolism, reduced red blood cell phagocytosis by AM whereas arachidonic acid had no effect on this cellular event. Neither arachidonic acid nor its metabolites (prostaglandins E 2, I 2, F 2∝, the thromboxane mimick U44069 and leukotrienes A 4, B 4, C 4, D 4) had a significant effect on phagocytosis. Inhibition of the synthesis of cycloxygenase products with various concentrations of indomethacin, aspirin and OKY-1581 or of lipoxygenase products with eicosatetraynoic acid, BW755C, diethylcarbamazine and phenidone did not affect phagocytosis either. On the other hand, asbestos-induced aggregation was significantly reduced by nordihydroguaiaretic acid (NDGA), BW755C, benoxaprofen, and high concentrations of indomethacin but not by aspirin. These results suggested that metabolites of arachidonic acid (especially lipoxygenase products) play a modulatory role in non specific alveolar macrophage aggregation but not in specific, Fc receptor-mediated phagocytosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
